Chris, I know you crunch numbers and data.
1. Can you see the potential signs of opportunists and profit takers taking opportunities here in this chart just after relisting, which may have further influenced the 'knife drop' with the price?
2. Did the falling Aussie and Global Cannabis index also influence decisions to sell out at that time, perhaps?
I think these are reasonable questions to ask and ponder for any shareholder who has been invested in the Cannabis sector over the past 4 years.
IMO, the data is very clear, which to me, indicates that the vast majority of stocks in the Cannabis sector were falling sharply in value at the time of the CGB relisting. It also supports what we continue to read in the media regarding an unreluctant and very conservative government continuing to delay legislation, as seen recently, that could help many patients who suffer chronic illnesses from getting access to medicinal Cannabis.
- Forums
- ASX - By Stock
- CGB
- Ann: Pause in Trading
Ann: Pause in Trading, page-59
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online